Although chemotherapy provides a potentially systemic cure for cancer, its application is hampered by a lack of exploitable differences between tumour cells and those which make up normal tissue. Even cells within the same tumour exhibit differing sensitivities to cytotoxic drugs, depending on factors such as their location in the cell cycle or distance from a blood supply. A further problem is increasing resistance of tumour cells to anticancer drugs.